Related references
Note: Only part of the references are listed.Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19
Delio Tedeschi et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2021)
The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study
Rinkoo Dalan et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 and Cardiovascular Disease
Kevin J. Clerkin et al.
CIRCULATION (2020)
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019
Xiaohua Chen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists
Maximilian F. Konig et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk
Alpo Vuorio et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
Mathieu Artifoni et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Hyperinflammatory shock in children during COVID-19 pandemic
Shelley Riphagen et al.
LANCET (2020)
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020
Nancy Chow et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020
Yixiang Ng et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Jin Liu et al.
EBIOMEDICINE (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Statin therapy in COVID-19 infection
Vincenzo Castiglione et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Roberto Scicali et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Considerations for Statin Therapy in Patients with COVID-19
Simin Dashti-Khavidaki et al.
PHARMACOTHERAPY (2020)
Statins: Could an old friend help in the fight against COVID-19?
Raul R. Rodrigues-Diez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality
Guoliang Li et al.
CARDIOLOGY JOURNAL (2020)
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science
Paul C. Evans et al.
CARDIOVASCULAR RESEARCH (2020)
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
Xiao-Jin Zhang et al.
CELL METABOLISM (2020)
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
Anton De Spiegeleer et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
Statin therapy improves endothelial dysfunction
Sarah Crunkhorn
NATURE REVIEWS DRUG DISCOVERY (2020)
Statins in coronavirus outbreak: It's time for experimental and clinical studies
Maurizio Bifulco et al.
PHARMACOLOGICAL RESEARCH (2020)
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study
Guillermo Rodriguez-Nava et al.
CRITICAL CARE (2020)
Coronary thrombosis in a young male with COVID-19
Abdullah Shams et al.
IDCASES (2020)
Influenza virus and atherosclerosis
A. Peretz et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2019)
Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure
H. Y. Duan et al.
GENETICS AND MOLECULAR RESEARCH (2015)
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients
Doruk Erkan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Statins directly suppress cytokine production in murine intraepithelial lymphocytes
Jiong Zhang et al.
CYTOKINE (2013)
A Clinical Evaluation of Statin Pleiotropy: Statins Selectively and Dose-Dependently Reduce Vascular Inflammation
Evelien van der Meij et al.
PLOS ONE (2013)
The increase in cholesterol levels at early stages after dengue virus infection. correlates with an augment in LDL particle uptake and HMG-CoA reductase activity
Ruben Soto-Acosta et al.
VIROLOGY (2013)
Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells
A. Iwata et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study
Meredith L. Vandermeer et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Systematic Review and Meta-Analysis on the Association between Outpatient Statins Use and Infectious Disease-Related Mortality
Yu Ma et al.
PLOS ONE (2012)
The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial
Victor Novack et al.
INTENSIVE CARE MEDICINE (2009)
Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2
Joerg Glende et al.
VIROLOGY (2008)
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia
EM Mortensen et al.
RESPIRATORY RESEARCH (2005)
Statin, like aspirin, should be given as early as possible in patients with acute coronary syndrome
CH Fang et al.
MEDICAL HYPOTHESES (2005)
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
DW McCarey et al.
LANCET (2004)
Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents?
U Schönbeck et al.
CIRCULATION (2004)
Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on coronary endothelial function
S Wassmann et al.
CIRCULATION RESEARCH (2003)
The effect of statins on mortality in patients with bacteremia
AP Liappis et al.
CLINICAL INFECTIOUS DISEASES (2001)
Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
MA Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)